Literature DB >> 16469527

Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells.

Shingo Hara1, Koh-Ichi Nakashiro, Sebastian K Klosek, Tohru Ishikawa, Satoru Shintani, Hiroyuki Hamakawa.   

Abstract

Hypoxia increases the invasive and metastatic potential of tumor cells. Increased expression of c-Met/hepatocyte growth factor (HGF)-receptor protein in response to hypoxia in thyroid papillary carcinomas is hypoxia-inducible factor-1 (HIF-1) dependent. Both HGF and c-Met are expressed in human salivary gland cancers. In the current study, we tested whether c-Met expression was regulated by hypoxia and HIF-1alpha using two human salivary gland cancer cell lines: GFP-ACC2 and GFP-ACCM. Hypoxia enhanced the expression of HIF-1alpha in both cell lines, whereas c-Met was markedly induced only in the GFP-ACCM cells, which have metastatic potential. In the latter, hypoxia also promoted HGF-induced invasiveness. Synthetic small-interfering RNA specific for HIF-1alpha inhibited HIF-1alpha expression in the GFP-ACCM cells, and also suppressed the increase in c-Met expression and HGF-induced invasiveness under hypoxic conditions. These results suggest that hypoxia activates the HGF/c-Met system via HIF-1alpha in human salivary gland cancers and might be involved in their metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469527     DOI: 10.1016/j.oraloncology.2005.10.016

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  31 in total

Review 1.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

2.  The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival.

Authors:  Qing-le Liang; Zheng-ying Mo; Ping Wang; Xiao Li; Zhi-xiang Liu; Zhang-ming Zhou
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.

Authors:  Vesselina G Cooke; Valerie S LeBleu; Doruk Keskin; Zainab Khan; Joyce T O'Connell; Yingqi Teng; Michael B Duncan; Liang Xie; Genta Maeda; Sylvia Vong; Hikaru Sugimoto; Rafael M Rocha; Aline Damascena; Ricardo R Brentani; Raghu Kalluri
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 4.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

Review 5.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

6.  The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma.

Authors:  Jun Kajihara; Yoshito Tomimaru; Hidetoshi Eguchi; Daisaku Yamada; Hiroshi Wada; Akira Tomokuni; Tadafumi Asaoka; Koichi Kawamoto; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

Review 7.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

8.  Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.

Authors:  Laura M S Seeber; Ronald P Zweemer; René H M Verheijen; Paul J van Diest
Journal:  Obstet Gynecol Int       Date:  2010-02-14

9.  Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway.

Authors:  Jeongki Kim; Yan Shao; Sang Yong Kim; Seyl Kim; Hyun Keun Song; Jun Ho Jeon; Hyun Woo Suh; Jin Woong Chung; Suk Ran Yoon; Young Sang Kim; Inpyo Choi
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

10.  Synthetic lethality: a framework for the development of wiser cancer therapeutics.

Authors:  William G Kaelin
Journal:  Genome Med       Date:  2009-10-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.